Mauna Kea Technologies
  • Physicians
    • Overview
    • Cellvizio system
    • Education
    • Reimbursement
    • GastroEnterology
    • Barrett’s Esophagus
    • Pancreatic Cysts
    • Gastric Disease
    • Inflammatory Bowel Diseases
    • Irritable Bowel Syndrome
    • Bilio-Pancreatic Strictures
    • Colorectal Lesions
    • Pulmonology
    • Lung Nodules
    • Covid-19
    • Urology
  • Investors
  • About us
    • Our story
    • Team
    • Board of Directors
    • Leadership
    • Join Us
    • Press Coverage
    • Commercial Network
  • News & events
  • US
  • INT
  • FR
Contact

News & Events

MKT Card.png
NEWS - Cellvizio
Jan 30, 2023

Mauna Kea Technologies announces the coverage of its stock by Portzamparc – Groupe BNP Paribas

Discover
MKT Card.png
NEWS - Cellvizio
Jan 26, 2023

Mauna Kea Technologies Announces Sales for the Fourth Quarter and Full Year 2022

Discover
Lung news and event.png
NEWS - Cellvizio
Jan 12, 2023

Mauna Kea Technologies Announces the Publication of Results of the First in Human Clinical Study Combining Robotic-Assisted Bronchoscopy and Needle-Based Confocal Laser Endomicroscopy for Lung Cancer

Discover
MKT Card.png
NEWS - Cellvizio
Nov 16, 2022

Mauna Kea Technologies reports its Financial Results for the First Half of 2022

Discover
MKT Card.png
NEWS - Cellvizio
Nov 7, 2022

Mauna Kea Technologies and Tasly Pharmaceutical Announce the Incorporation of Joint Venture in China

Discover
Untitled design (6).png
NEWS - Cellvizio
Oct 31, 2022

Mauna Kea Technologies Announces Success of Clinical Trial on Prediction of Remission in Patients with Inflammatory Bowel Disease (IBD) and its Publication in Gastroenterology

Discover
See more
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
  • Legal notice
  • Join Us
  • Contact us
  • Cellvizio.net
  • DiagnosingBarretts.org
  • DiagnosingPancreaticCysts.org
Mauna Kea Technologies